Trial NCT01488253

View at ClinicalTrials.gov 
Org. Study IDs: KSBMT2011-01

Last trial update was posted on 2015-04-03

MeSH Interventions

MTOR Inhibitors Sirolimus Tacrolimus Temsirolimus

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Accelerated Phase Leukemia, Myeloid, Chronic-Phase Myelodysplastic Syndromes

Other Conditions

Acute Leukemia in Remission Leukemia, Myeloid, Accelerated-Phase

Stopping Reasons

We could not receive the support from the national medical insurance owing to the changed policy of the government for clincal trials.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID